Fecal occult blood test

The Mayo Clinic Diet Book, learn more

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Results

By Mayo Clinic staff

Living With Cancer

Subscribe to our Living With Cancer e-newsletter to stay up to date on cancer topics.

Sign up now

Your doctor will review the results of the fecal occult blood test and then share the results with you.

  • Negative result. A fecal occult blood test is considered negative if no blood is detected in your stool samples. If you had the test to screen for colon cancer and you're at average risk — you have no colon cancer risk factors other than age — your doctor may recommend waiting one year and then repeating the test.
  • Positive result. A fecal occult blood test is considered positive if blood is detected in your stool samples. You may need additional testing — such as a colonoscopy — to locate the source of the bleeding.

It's important to remember that false-negative and false-positive results are possible. Some cancers and most polyps don't bleed, which may lead to a false-negative result. Likewise, occult bleeding may come from sources other than colon cancer or a polyp — a false-positive — such as from a stomach ulcer, hemorrhoid, or even blood swallowed from your mouth or nose.

References
  1. Fecal occult blood test: The test sample. American Association for Clinical Chemistry. http://www.labtestsonline.org/understanding/analytes/fecal_occult_blood/test.html. Accessed April 12, 2011.
  2. Fletcher RH. Tests for screening for colorectal cancer: Stool tests, radiologic imaging and endoscopy. http://www.uptodate.com/home/index.html. Accessed April 12, 2011.
  3. Labianca R, et al. Screening and diagnosis for colorectal cancer: present and future. Tumori. 2010;96:889.
  4. American Cancer Society guidelines for the early detection of cancer. American Cancer Society. http://www.cancer.org/docroot/PED/content/PED_2_3X_ACS_Cancer_Detection_Guidelines_36.asp?sitearea=PED. Accessed April 12, 2011.
  5. Lieberman D. Progress and Challenges in Colorectal Cancer Screening and Surveillance. Gastroenterology. 2010;138:2115.
  6. Levin B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570.
  7. Doppler JM (expert opinion). Mayo Clinic, Rochester, Minn. June 8, 2011.
MY00620 June 18, 2011

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger